What are the mechanics of hemodialysis in adults with end-stage renal disease, particularly those with a history of chronic conditions like diabetes or hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mechanics of Hemodialysis

Core Transport Mechanisms

Hemodialysis removes uremic toxins and excess fluid through two fundamental physical processes: diffusion and convection, both occurring across a semipermeable membrane that separates blood from dialysate. 1, 2

Diffusion (Primary Mechanism for Small Solutes)

  • Diffusion operates according to Fick's law, where solutes move down their concentration gradient from blood (high concentration) to dialysate (low concentration) across the semipermeable membrane 1, 3
  • Small molecular weight solutes (urea, creatinine, potassium) are primarily removed by diffusion 1, 2
  • Diffusive transport efficiency depends on three critical compartments: the blood compartment, the membrane itself, and the dialysate compartment 3
  • The dialysate composition resembles plasma water with electrolytes adjusted to compensate for abnormalities of end-stage renal disease 4

Convection (Solvent Drag)

  • Convection removes larger molecular-weight solutes through ultrafiltration and solvent drag, where solutes are carried along with plasma water as it moves across the membrane 1, 2
  • Ultrafiltration is the primary mechanism for removing excess plasma water and achieving volume control 1, 5
  • Internal filtration within high-flux dialyzers significantly enhances convective solute removal even during standard hemodialysis 3, 2

Membrane Technology and Filter Design

Membrane Characteristics

  • Modern hollow fiber membranes dominate current practice, containing thousands of tiny capillary-like fibers through which blood flows 3, 2
  • Membranes are classified by water permeability (low-flux vs. high-flux) and composition (cellulosic vs. synthetic) 2
  • High-flux membranes with enhanced permeability allow greater removal of middle molecules while maintaining acceptable albumin retention 2, 3
  • Newer membrane properties include hydrophilicity, adsorption capacity, and electrical potential, which affect biocompatibility and solute removal 2

Blood-Membrane-Dialysate Interface

  • Blood flows through the inside of hollow fibers at 200-500 mL/min while dialysate flows countercurrent on the outside at 500-800 mL/min 3
  • The countercurrent flow maximizes the concentration gradient across the membrane, optimizing diffusive clearance 1, 3
  • Blood/membrane interactions critically influence filtration-based therapies and can affect biocompatibility 3

Ultrafiltration and Volume Management

Ultrafiltration Mechanics

  • Ultrafiltration removes fluid by applying transmembrane pressure, forcing plasma water across the membrane while retaining blood cells and proteins 1, 5
  • The ultrafiltration rate must not exceed the plasma refill rate from interstitial compartments to avoid intravascular volume depletion 6, 7
  • Ultrafiltration rates exceeding 13 mL/kg/hour exceed plasma refill capacity and cause hypotension, myocardial stunning, and loss of residual kidney function 7

Critical Volume Control Principles

  • Volume overload from sodium and water retention is the primary cause of hypertension in hemodialysis patients 5
  • Achievement of dry weight through adequate ultrafiltration and sodium restriction (≤5.8 g sodium chloride daily) is essential for blood pressure control 5
  • Excessive ultrafiltration is the leading cause of intradialytic hypotension, occurring in 20-30% of treatments 7, 6

Dialysis Prescription Parameters

Standard Thrice-Weekly Hemodialysis

  • Target single-pool Kt/V of 1.4 per session with minimum delivered dose of 1.2 for patients treated three times weekly 5
  • Minimum treatment time of 3 hours per session for patients with minimal residual kidney function (<2 mL/min) 5
  • Blood flow rates typically 200-500 mL/min and dialysate flow rates 500-800 mL/min optimize clearance 3

Dialysate Composition

  • Dialysate bicarbonate concentration should be 35-38 mmol/L to prevent metabolic acidosis, with target predialysis serum bicarbonate ≥22 mmol/L 8, 5
  • Dialysate glucose concentration affects post-dialysis glycemic control; glucose-free dialysates are now preferred to avoid hyperglycemia 5
  • Dialysate temperature reduction improves hemodynamic stability during ultrafiltration 6, 7

Special Populations and Complications

Diabetes and Hemodialysis

  • Patients with diabetes on hemodialysis experience frequent hypoglycemia requiring insulin dose reduction of approximately 40-50% due to decreased renal insulin clearance and gluconeogenesis 5
  • Insulin is the preferred antihyperglycemic agent for dialysis patients with diabetes requiring medication 9
  • Glycemic variability increases during and after hemodialysis due to glucose removal, altered insulin clearance, and dialysate glucose concentration 5

Hemodynamic Management

  • Intradialytic hypotension prevention requires limiting ultrafiltration rate, increasing treatment time, reducing dialysate temperature, and avoiding food during dialysis 7, 6
  • Paradoxical intradialytic hypertension occurs in 5-15% of patients and requires strict sodium restriction and dry weight reassessment 7
  • Maintaining mean arterial pressure in the normal range is critical to optimize forward flow and prevent end-organ damage 5

Critical Pitfalls to Avoid

  • Never use aggressive ultrafiltration rates >13 mL/kg/hour, as this causes severe hypotension and accelerates loss of residual kidney function 7
  • Do not ignore bicarbonate levels between 18-22 mmol/L—this range causes protein catabolism and bone disease requiring intervention 8
  • Never delay emergency dialysis for life-threatening indications (uremic pericarditis, encephalopathy, refractory hyperkalemia) to achieve "optimal" vascular access; place temporary catheter immediately 7
  • Preserve peripheral veins in patients with stage III-V chronic kidney disease for future arteriovenous access creation 9
  • Avoid citrate-containing alkali preparations in dialysis patients, as they dramatically increase aluminum absorption 8

References

Research

Basic mechanisms governing solute and fluid transport in hemodialysis.

Hemodialysis international. International Symposium on Home Hemodialysis, 2008

Research

Haemodialysis membranes.

Nature reviews. Nephrology, 2018

Research

Hemodialysis. Basic principles and practice.

Postgraduate medicine, 1985

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hemodialysis Complications and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Emergency Indications for Dialysis in CKD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Decreased CO2 Levels in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

End-Stage Renal Disease: Medical Management.

American family physician, 2021

Related Questions

What is the management plan for a 48-year-old female with impaired renal function (eGFR 65)?
What is erythema infectiosum (Fifth disease)?
What is the best treatment approach for a 65-year-old male with End-Stage Renal Disease (ESRD) on dialysis and a Gleason score 8 prostate cancer with no evidence of metastasis?
What home health interventions are appropriate for a 74-year-old female with hypertension, hyperlipidemia, end-stage renal disease (ESRD) on dialysis, anxiety disorder, insomnia, gastroesophageal reflux disease (GERD), generalized muscle weakness, and urinary incontinence, taking medications including quetiapine (Seroquel) 25mg, alprazolam 0.5mg, cetirizine (Zyrtec) 10mg, amlodipine 10mg, esomeprazole (Nexium) 40mg, labetalol 200mg, losartan 100mg, furosemide 40mg, zolpidem 12.5mg, sevelamer 800mg, and albuterol sulfate, with normal vitals and hypotension, and an allergy to codeine?
What is the most appropriate next step in managing a 32-year-old woman with Systemic Lupus Erythematosus (SLE) and newly diagnosed Hypertension (high blood pressure) and Nephrotic Syndrome (characterized by severe proteinuria), currently treated with Prednisone (corticosteroid)?
What is the relationship between vitamin D levels and obsessive-compulsive disorder (OCD) in patients?
When should the risk tolerance of modified World Health Organization (WHO) maternal cardiovascular risk be used in women with pre-existing cardiovascular conditions, such as heart disease or hypertension, who are pregnant or planning pregnancy?
What is the best course of action for a patient with chronic prostatitis, who has undergone multiple 6-week courses of amoxicillin (amoxicillin) with only temporary relief, has a history of Enterococcus faecalis infection sensitive to amoxicillin, vancomycin, and linezolid, but resistant to ciprofloxacin (ciprofloxacin), and experiences immediate symptom recurrence after stopping treatment?
What is the treatment approach for a patient with cervical perineural cysts?
Does prednisolone use increase the risk of sepsis in a patient with a recent history of antibiotic exposure and a traumatic tendon rupture?
Does steroid use increase the risk of sepsis in a patient with pneumonia, particularly one with a recent history of antibiotic exposure and a traumatic tendon rupture?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.